Island Pharmaceuticals Ltd (ILA) — Net Asset Quality Index
Island Pharmaceuticals Ltd (ILA) has a Net Asset Quality Index of 95.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$7.49 Million minus total liabilities of AU$336.43K yields net assets of AU$7.16 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ILA total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Island Pharmaceuticals Ltd Net Asset Quality Index Over Time (2019–2024)
This chart shows how Island Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 95.5%, representing net assets of AU$7.16 Million against total assets of AU$7.49 Million AUD. For live market cap and overall valuation, see Island Pharmaceuticals Ltd stock valuation.
Annual Net Asset Quality Index for Island Pharmaceuticals Ltd (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for Island Pharmaceuticals Ltd from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Island Pharmaceuticals Ltd shareholders equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.5% | AU$7.16 Million | AU$7.49 Million | AU$336.43K | ▲ +36.3 pp |
| 2023 | 59.2% | AU$1.52 Million | AU$2.56 Million | AU$1.05 Million | ▼ -27.9 pp |
| 2022 | 87.1% | AU$1.79 Million | AU$2.05 Million | AU$263.85K | ▼ -1.0 pp |
| 2021 | 88.1% | AU$4.32 Million | AU$4.90 Million | AU$580.73K | ▼ -8.3 pp |
| 2020 | 96.4% | AU$6.40 Million | AU$6.64 Million | AU$236.83K | ▲ +3961.1 pp |
| 2019 | -3864.7% | AU$-657.00 | AU$17.00 | AU$674.00 | — |